Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medinsa, officially known as Laboratorios Medicamentos Internacionales, is a prominent Spanish pharmaceutical company specializing in the development and manufacture of solid oral dosage forms. Located in Madrid, the company operates as a high-capacity Contract Development and Manufacturing Organization (CDMO) and a producer of generic pharmaceuticals. Their service portfolio encompasses the entire product lifecycle, from initial formulation and pilot batches to full-scale commercial production and packaging. Medinsa is a subsidiary of the Aristo Pharma Group, which is part of the Medice Health Family, providing them with extensive international reach. The facility is EU-GMP certified and features specialized capabilities for handling complex oral solids, including pellets and multi-layer tablets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Medicamentos Internacionales.